News Center American Regent is a leading manufacturer and marketer of generic and branded specialty injectables. We have been able to achieve an admirable level of success, not only due to our own initiatives, but also because of the success of strategic partnerships.

American Regent announces the commercial availability of Busulfan Injection, the first and only AP-rated therapeutically equivalent generic to Busulfex®
Shirley, NY (March 1, 2017) - American Regent today announced the launch of Busulfan Injection which had been previously approved by the U.S. Food and Drug Administration.
Read the full press release

© 2017, American Regent, Inc., A Luitpold Pharmaceuticals, Inc. Company
PP-AS-US-0014     4/2017